- Report
- January 2026
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- January 2026
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- January 2026
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- January 2026
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- November 2025
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- October 2025
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- October 2025
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- October 2025
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- October 2025
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- October 2025
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- October 2025
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- October 2025
- 160 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- August 2025
- 150 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- August 2025
- 150 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- January 2026
- 107 Pages
Global
From €3500EUR$4,154USD£3,141GBP
- Report
- August 2025
- 88 Pages
Global
From €3500EUR$4,154USD£3,141GBP
- Report
- November 2025
- 160 Pages
Global
From €4377EUR$4,850USD£3,795GBP
- Report
- October 2025
- 163 Pages
Global
From €4377EUR$4,850USD£3,795GBP
- Report
- February 2026
- 190 Pages
Global
From €4377EUR$4,850USD£3,795GBP
- Report
- August 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,795GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more